Atovaquone And Proguanil Hcl Tablet, Film Coated
Product Images NDC 66993-060

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hcl (NDC 66993-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquone Molecular Chemical Structure.jpg (Atovaquone Proguanil Spl Graphic 01)

Chemical structure diagram of the active ingredient atovaquone from the Atovaquone and Proguanil HCl tablet product.*

FDA Label Image

Proguanil Hydrochloride Molecular Chemical Structure.jpg (Atovaquone Proguanil Spl Graphic 02)

Chemical structure of atovaquone and proguanil hydrochloride, showing the molecular arrangement including rings, nitrogen, chlorine, and methyl groups, along with an HCl component.*

FDA Label Image

100 Tablet Bottle Label (Atovaquone Proguanil Spl Graphic 03)

Label for Atovaquone and Proguanil HCl tablets, film coated, containing 250 mg atovaquone and 100 mg proguanil hydrochloride per tablet. The label indicates a package of 100 tablets for prescription use only, manufactured for Prasco Laboratories. Storage instructions and manufacturer details including GlaxoSmithKline are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.